Prader-Willi syndrome; oculocutaneous albinism |
OCA2 |
15q12-q13.1 |
p. Val443Ile; c. 1327G>A |
mother is heterozygous carrier |
del(15)(q11.2q13.1) |
nd |
paternal |
Lee et al., 1994 |
|
VCF/DiGeorge syndrome; Bernard-Soulier syndrome |
GP1BB |
22q11.21 |
c. −133C>G |
nd |
del(22)(q11.2q11.2) |
nd |
nd |
Ludlow et al., 1996 |
|
MR, retinoblastoma + Wilson disease |
ATP7B |
13q14.3 |
nd |
maternal |
del(13)(q14.2q21.1) |
nd |
paternal |
Riley et al., 2001 |
|
Smith-Magenis syndrome; sensorineural hearing loss |
MYO15A |
17p11.2 |
p. Thr2205Ile; c. 6614C>T |
mother is heterozygous carrier |
del(17)(p11.2p11.2) |
nd |
paternal |
Liburd et al., 2001 |
|
Angelman syndrome; oculocutaneous albinism |
OCA2 |
15q12-q13.1 |
c. 647-?_807+?del (deletion of exon 7) |
father is heterozygous carrier |
del(15)(q11.2q13.1) |
∼5 |
maternal |
Fridman et al., 2003 |
|
Williams syndrome; chronic granulomatous disease |
NCF1 |
7q11.23 |
p. Tyr26fs; c. 75-76del |
nd |
del(7)(q11.23q11.23) |
nd |
nd |
Kabuki et al., 2003 |
|
Sotos syndrome; reduced coagulation factor 12 activity |
F12 |
5q35.3 |
c. −4C>T (rs1801020) |
nd |
del(5)(q35.3q35.3) |
2.2 |
nd |
Kurotaki et al., 2005 |
|
22q11 del syndrome; psychotic disorder |
COMT |
22q11.21 |
p. Val158Met; c. 472G>A |
nd |
del(22)(q11.2q11.2) |
nd |
nd |
Gothelf et al., 2005 |
|
Wolf-Hirschhorn syndrome; Wolfram syndrome |
WFS1 |
4p16.1 |
p. Gln366X; c. 1096C>T |
mother is heterozygous carrier |
inv dup del(4) (:p15.33→p16.1::p16.1→qter) |
8.3 |
paternal |
Flipsen-ten Berg et al., 2007 |
|
22q13 del syndrome; metachromatic leukodystrophy |
ARSA |
22q13.33 |
p. Pro426Leu c. 1277C>T |
nd |
del(22)(q13.2qter).ish cgh dup(13)(q22qter) |
∼8 |
nd |
Bisgaard et al., 2009 |
|
Werner syndrome |
WRN |
8p12 |
p. Tyr57X; c. 171C>G |
nd |
del (8)(p12p12) |
0.553 |
nd |
Friedrich et al., 2010 |